19:13 Debate: Surgery versus stereotactic body radiation therapy in early stage NSCLC - Surgery HMP Education
24:50 Debate: Surgery versus stereotactic body radiation therapy in early stage NSCLC - SBRT HMP Education
19:33 Attempts to integrate novel targeted agents and immunotherapy into the combined modality paradigm HMP Education
17:27 How, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR positive NSCLC HMP Education
19:20 Communicating with patients and families: Managing expectations as hope and reality collide HMP Education
15:04 Debate: Targeting the immune system with checkpoint inhibitors - Single drug therapy HMP Education
23:11 Debate: Targeting the immune system with checkpoint inhibitors - Combination therapy HMP Education
17:56 Expanding beyond the checkpoints: New vaccines and other immunologic strategies for NSCLC HMP Education
